Verification evidence is still being completed.
PDF / print export
Charles River Laboratories Finland
Kuopio, Finland
- Verified lead
- James C. Foster
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chairman, President and CEO
- 2026 technical specialization
- CRO, Neuroscience Discovery, In Vivo Pharmacology, Imaging, Biomarker Analysis, and Translational Research
- Review cycle
- May 2026
- Full address
- Kuopio, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Charles River page confirming the Kuopio, Finland discovery facility.
- Editorial note
- Charles River Laboratories Finland is published because official company materials confirm corporate leadership, a real Kuopio discovery facility, and a strong Finnish CRO footprint in translational pharmacology.
CRO, Neuroscience Discovery, In Vivo Pharmacology, Imaging, Biomarker Analysis, and Translational Research
Official leadership disclosure, Official Kuopio facility disclosure, Discovery-services platform claim
Charles River Laboratories Finland is published because official company materials confirm corporate leadership, a real Kuopio discovery facility, and a strong Finnish CRO footprint in translational pharmacology.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Charles River Laboratories Finland runs translational pharmacology, neuroscience discovery services, and advanced imaging and biomarker analysis in Kuopio, Finland.
- Lead
- James C. Foster (verified ↗)
- Address
- Kuopio, Finland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Large discovery-services platform
- Capabilities
- Translational Pharmacology · Neuroscience Discovery Services · Advanced Imaging and Biomarker Analysis
- Founded
- 1947
- Headcount
- 10000+
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
James C. Foster
Chairman, President and CEO
Full addressKuopio, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Charles River Kuopio facility page confirming the Kuopio location.
Open sourceLarge discovery-services platform
Kuopio, Finland. CRO, Neuroscience Discovery, In Vivo Pharmacology, Imaging, Biomarker Analysis, and Translational Research. Review completed on 22 Mar 2026.
Finnish research, animal-welfare, and CRO oversight
Official leadership disclosure, Official Kuopio facility disclosure, Discovery-services platform claim
CRO, Neuroscience Discovery, In Vivo Pharmacology, Imaging, Biomarker Analysis, and Translational Research
Charles River Laboratories Finland is published because official company materials confirm corporate leadership, a real Kuopio discovery facility, and a strong Finnish CRO footprint in translational pharmacology.
Editorial note
Charles River Laboratories Finland is published because official company materials confirm corporate leadership, a real Kuopio discovery facility, and a strong Finnish CRO footprint in translational pharmacology.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Translational Pharmacology
Neuroscience Discovery Services
Advanced Imaging and Biomarker Analysis
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Small-animal imaging core facilities
Behavioral and physiological testing facilities
Dedicated vivarium and surgical suites
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Charles River Laboratories Finland located?
- Charles River Laboratories Finland operates from Kuopio, Finland, Kuopio, Finland.
- Who runs Charles River Laboratories Finland?
- Charles River Laboratories Finland is led by James C. Foster, Chairman, President and CEO. Verified 22 Mar 2026.
- What does Charles River Laboratories Finland do?
- Charles River Laboratories Finland runs translational pharmacology, neuroscience discovery services, and advanced imaging and biomarker analysis in Kuopio, Finland. Core capabilities: Translational Pharmacology, Neuroscience Discovery Services, Advanced Imaging and Biomarker Analysis.
Editorial context
Related technical briefs
Briefs that name Kuopio as a covered market or city.